Back to results
US 2019/0169579 A1Published application
Respiratory Syncytial Virus Expression Vectors
AssigneesEmory University, Children's Healthcare of Atlanta, Inc.
InventorsMartin L. Moore, Anne Hotard
Life of this patent
Estimating the term…
Abstract
In certain embodiments, the disclosure relates to vectors containing bacterial nucleic acid sequences and a paramyxovirus gene. Typically, the expression vector comprises a bacterial artificial chromosome (BAC), and a nucleic acid sequence comprising a respiratory syncytial virus (RSV) gene in operable combination with a regulatory element and optionally a reporter gene.
Claims10
A nucleic acid comprising SEQ ID NO:
- 4.
A nucleic acid comprising SEQ ID NO:
- 5.
A nucleic acid comprising SEQ ID NO:
- 4 and SEQ ID NO:
- 5.
A nucleic acid comprising the restriction sites BstBI, SacI, ClaI, AvrII, and MluI, in that order.
Dependencies are inferred from the claim text.